| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
1 | AN ACT concerning criminal law.
| |||||||||||||||||||
2 | Be it enacted by the People of the State of Illinois,
| |||||||||||||||||||
3 | represented in the General Assembly:
| |||||||||||||||||||
4 | Section 5. The Illinois Controlled Substances Act is | |||||||||||||||||||
5 | amended by changing Section 206 as follows:
| |||||||||||||||||||
6 | (720 ILCS 570/206) (from Ch. 56 1/2, par. 1206)
| |||||||||||||||||||
7 | Sec. 206. (a) The controlled substances listed in this | |||||||||||||||||||
8 | Section are
included in Schedule II.
| |||||||||||||||||||
9 | (b) Unless specifically excepted or unless listed in | |||||||||||||||||||
10 | another
schedule, any of the following substances whether | |||||||||||||||||||
11 | produced directly or
indirectly by extraction from substances | |||||||||||||||||||
12 | of vegetable origin, or
independently by means of chemical | |||||||||||||||||||
13 | synthesis, or by combination of
extraction and chemical | |||||||||||||||||||
14 | synthesis:
| |||||||||||||||||||
15 | (1) Opium and opiates, and any salt, compound, | |||||||||||||||||||
16 | derivative or
preparation of opium or opiate, excluding | |||||||||||||||||||
17 | apomorphine, dextrorphan,
levopropoxyphene,
nalbuphine, | |||||||||||||||||||
18 | nalmefene, naloxone, and naltrexone, and their respective
| |||||||||||||||||||
19 | salts, but including the following:
| |||||||||||||||||||
20 | (i) Raw Opium;
| |||||||||||||||||||
21 | (ii) Opium extracts;
| |||||||||||||||||||
22 | (iii) Opium fluid extracts;
| |||||||||||||||||||
23 | (iv) Powdered opium;
|
| |||||||
| |||||||
1 | (v) Granulated opium;
| ||||||
2 | (vi) Tincture of opium;
| ||||||
3 | (vii) Codeine;
| ||||||
4 | (viii) Ethylmorphine;
| ||||||
5 | (ix) Etorphine Hydrochloride;
| ||||||
6 | (x) Hydrocodone;
| ||||||
7 | (xi) Hydromorphone;
| ||||||
8 | (xii) Metopon;
| ||||||
9 | (xiii) Morphine;
| ||||||
10 | (xiii.5) 6-Monoacetylmorphine; | ||||||
11 | (xiv) Oxycodone;
| ||||||
12 | (xv) Oxymorphone;
| ||||||
13 | (xv.5) Tapentadol; | ||||||
14 | (xvi) Thebaine;
| ||||||
15 | (xvii) Thebaine-derived butorphanol.
| ||||||
16 | (xviii) Methorphan, except drug products | ||||||
17 | containing dextromethorphan that may be dispensed | ||||||
18 | pursuant to a prescription order of a practitioner and | ||||||
19 | are sold in compliance with the safety and labeling | ||||||
20 | standards as set forth by the United States Food and | ||||||
21 | Drug Administration, or drug products containing | ||||||
22 | dextromethorphan that are sold in solid, tablet, | ||||||
23 | liquid, capsule, powder, thin film, or gel form and | ||||||
24 | which are formulated, packaged, and sold in dosages | ||||||
25 | and concentrations for use as an over-the-counter drug | ||||||
26 | product. For the purposes of this Section, |
| |||||||
| |||||||
1 | "over-the-counter drug product" means a drug that is | ||||||
2 | available to consumers without a prescription and sold | ||||||
3 | in compliance with the safety and labeling standards | ||||||
4 | as set forth by the United States Food and Drug | ||||||
5 | Administration.
| ||||||
6 | (2) Any salt, compound, isomer, derivative or | ||||||
7 | preparation thereof
which is chemically equivalent or | ||||||
8 | identical with any of the substances
referred to in | ||||||
9 | subparagraph (1), but not including the isoquinoline
| ||||||
10 | alkaloids of opium;
| ||||||
11 | (3) Opium poppy and poppy straw;
| ||||||
12 | (4) Coca leaves and any salt, compound, isomer, salt | ||||||
13 | of an isomer,
derivative, or preparation of coca leaves | ||||||
14 | including cocaine or ecgonine,
and any salt, compound, | ||||||
15 | isomer, derivative, or preparation thereof which is
| ||||||
16 | chemically equivalent or identical with any of these | ||||||
17 | substances, but not
including decocainized coca leaves or | ||||||
18 | extractions of coca leaves which do
not contain cocaine or | ||||||
19 | ecgonine (for the purpose of this paragraph, the
term | ||||||
20 | "isomer" includes optical, positional and geometric | ||||||
21 | isomers);
| ||||||
22 | (5) Concentrate of poppy straw (the crude extract of | ||||||
23 | poppy straw in
either liquid, solid or powder form which | ||||||
24 | contains the phenanthrine
alkaloids of the opium poppy).
| ||||||
25 | (c) Unless specifically excepted or unless listed in | ||||||
26 | another
schedule any of the following opiates, including their |
| |||||||
| |||||||
1 | isomers, esters,
ethers, salts, and salts of isomers, whenever | ||||||
2 | the existence of these
isomers, esters, ethers and salts is | ||||||
3 | possible within the specific
chemical designation, dextrorphan | ||||||
4 | excepted:
| ||||||
5 | (1) Alfentanil;
| ||||||
6 | (1.1) Carfentanil;
| ||||||
7 | (1.2) Thiafentanyl; | ||||||
8 | (2) Alphaprodine;
| ||||||
9 | (3) Anileridine;
| ||||||
10 | (4) Bezitramide;
| ||||||
11 | (5) Bulk Dextropropoxyphene (non-dosage forms);
| ||||||
12 | (6) Dihydrocodeine;
| ||||||
13 | (7) Diphenoxylate;
| ||||||
14 | (8) Fentanyl;
| ||||||
15 | (8.5) Xylazine: (N-2,6-dimethylpheny1)-5,6- | ||||||
16 | dihydro-4H-1,3 thiazin-2-amine), including its isomers, | ||||||
17 | esters, ethers, salts, and salts of isomers, esters, and | ||||||
18 | ethers, whenever the existence of such isomers, esters, | ||||||
19 | ethers, and salts is possible within the specific chemical | ||||||
20 | designation; | ||||||
21 | (9) Sufentanil;
| ||||||
22 | (9.5) Remifentanil;
| ||||||
23 | (10) Isomethadone;
| ||||||
24 | (11) (Blank);
| ||||||
25 | (12) Levorphanol (Levorphan);
| ||||||
26 | (13) Metazocine;
|
| |||||||
| |||||||
1 | (14) Methadone;
| ||||||
2 | (15) Methadone-Intermediate,
| ||||||
3 | 4-cyano-2-dimethylamino-4,4-diphenyl-1-butane;
| ||||||
4 | (16) Moramide-Intermediate,
| ||||||
5 | 2-methyl-3-morpholino-1,1-diphenylpropane-carboxylic
| ||||||
6 | acid;
| ||||||
7 | (17) Pethidine (meperidine);
| ||||||
8 | (18) Pethidine-Intermediate-A,
| ||||||
9 | 4-cyano-1-methyl-4-phenylpiperidine;
| ||||||
10 | (19) Pethidine-Intermediate-B,
| ||||||
11 | ethyl-4-phenylpiperidine-4-carboxylate;
| ||||||
12 | (20) Pethidine-Intermediate-C,
| ||||||
13 | 1-methyl-4-phenylpiperidine-4-carboxylic acid;
| ||||||
14 | (21) Phenazocine;
| ||||||
15 | (22) Piminodine;
| ||||||
16 | (23) Racemethorphan;
| ||||||
17 | (24) (Blank);
| ||||||
18 | (25) Levo-alphacetylmethadol (some other names:
| ||||||
19 | levo-alpha-acetylmethadol,
levomethadyl acetate, LAAM).
| ||||||
20 | (d) Unless specifically excepted or unless listed in | ||||||
21 | another
schedule, any material, compound, mixture, or | ||||||
22 | preparation which contains
any quantity of the following | ||||||
23 | substances having a stimulant effect on
the central nervous | ||||||
24 | system:
| ||||||
25 | (1) Amphetamine, its salts, optical isomers, and salts | ||||||
26 | of its
optical isomers;
|
| |||||||
| |||||||
1 | (2) Methamphetamine, its salts, isomers, and salts of | ||||||
2 | its isomers;
| ||||||
3 | (3) Phenmetrazine and its salts;
| ||||||
4 | (4) Methylphenidate;
| ||||||
5 | (5) Lisdexamfetamine. | ||||||
6 | (e) Unless specifically excepted or unless listed in | ||||||
7 | another
schedule, any material, compound, mixture, or | ||||||
8 | preparation which contains
any quantity of the following | ||||||
9 | substances having a depressant effect on
the central nervous | ||||||
10 | system, including its salts, isomers, and salts of
isomers | ||||||
11 | whenever the existence of such salts, isomers, and salts of
| ||||||
12 | isomers is possible within the specific chemical designation:
| ||||||
13 | (1) Amobarbital;
| ||||||
14 | (2) Secobarbital;
| ||||||
15 | (3) Pentobarbital;
| ||||||
16 | (4) Pentazocine;
| ||||||
17 | (5) Phencyclidine;
| ||||||
18 | (6) Gluthethimide;
| ||||||
19 | (7) (Blank).
| ||||||
20 | (f) Unless specifically excepted or unless listed in | ||||||
21 | another schedule,
any material, compound, mixture, or | ||||||
22 | preparation which contains any quantity
of the following | ||||||
23 | substances:
| ||||||
24 | (1) Immediate precursor to amphetamine and | ||||||
25 | methamphetamine:
| ||||||
26 | (i) Phenylacetone
|
| |||||||
| |||||||
1 | Some trade or other names: phenyl-2-propanone;
| ||||||
2 | P2P; benzyl methyl ketone; methyl benzyl ketone.
| ||||||
3 | (2) Immediate precursors to phencyclidine:
| ||||||
4 | (i) 1-phenylcyclohexylamine;
| ||||||
5 | (ii) 1-piperidinocyclohexanecarbonitrile (PCC).
| ||||||
6 | (3) Nabilone.
| ||||||
7 | (Source: P.A. 100-368, eff. 1-1-18 .)
|